Myeloid‐specific dopamine D2 receptor signalling controls inflammation in acute pancreatitis via inhibiting M1 macrophage
- 14 February 2020
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 177 (13) , 2991-3008
Abstract
Background and Purpose: Macrophage infiltration and activation is a critical step during acute pancreatitis (AP). We have shown that pancreas‐specific D2 receptor signalling protects against AP severity. As it is unclear to what extent myeloid‐specific D2 receptor mediates AP, we investigated the role of myeloid‐specific D2 receptor signalling in AP.Experimental Approach: Using wild‐type and LysM+/creD2fl/fl mice, AP was induced by l‐arginine, caerulein and LPS. Murine bone marrow‐derived macrophages and human peripheral blood mononuclear cells (PBMCs) were isolated, cultured and then induced to M1 phenotype. AP severity was assessed by measurements of serum amylase and lipase and histological grading. Macrophage phenotype was assessed by flow cytometry and qRT‐PCR. NADPH oxidase‐induced oxidative stress and NF‐κB and NLRP3 inflammasome signalling pathways were also evaluated.Key Results: We found that dopaminergic system was activated and dopamine reduced inflammatory cytokine expression in M1‐polarized macrophages from human PBMCs. Dopaminergic synthesis was also activated, but D2 receptor expression was down‐regulated in M1‐polarized macrophages from murine bone marrows. During AP, myeloid‐specific D2 receptor deletion worsened pancreatic injury, systematic inflammation and promoted macrophages to M1 phenotype. Furthermore, M1 macrophages from LysM+/creD2fl/fl mice exhibited increased NADPH oxidase‐induced oxidative stress and enhanced NF‐κB and NLRP3 inflammasome activation. D2 receptor activation inhibited M1 macrophage polarization, oxidative stress‐induced NF‐κB and NLRP3 inflammasome activation.Conclusion and Implications: Our data for the first time showed that myeloid‐specific D2 receptor signalling controls pancreatic injury and systemic inflammation via inhibiting M1 macrophage, suggesting D2 receptor activation might serve as therapeutic target for AP.Keywords
Funding Information
- National Natural Science Foundation of China (81400663, 81570580, 81670584, 81900584, 81900585, 81970556)
This publication has 47 references indexed in Scilit:
- CLEC5A is critical for dengue virus–induced inflammasome activation in human macrophagesBlood, 2013
- Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallinNature, 2012
- Macrophage plasticity and polarization: in vivo veritasJournal of Clinical Investigation, 2012
- Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesisNature, 2011
- Inhibition of NADPH oxidase promotes alternative and anti‐inflammatory microglial activation during neuroinflammationJournal of Neurochemistry, 2011
- TLR signalling augments macrophage bactericidal activity through mitochondrial ROSNature, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- The immunoregulatory role of dopamine: An updateBrain, Behavior, and Immunity, 2010
- Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMPBlood, 2008
- Experimental acute pancreatitis in PAP/HIP knock-out miceGut, 2007